- Ennislaw

08/01/2011 - On June 15, 2011, the U.S. Food and Drug Administration (FDA) required added warnings on the label of the diabetes medication, Actos (pioglitazone), which is manufactured by Takeda Pharmaceuticals, stating that it may increase the risk of bladder cancer when taken for more than one year, reports Ennis & Ennis, P.A. This warning came shortly after France and Germany suspended the use of pioglitazone. Meanwhile, just last week, the European Medicines Agency (EMA) announced that Actos may be put back on the European market, but with new contra-indications because the “benefit-risk balance remains positive in a limited population of Type II diabetics”. More specifically, the EMA advises physicians to carefully monitor the patients and to review the patients after three to six months (and regularly thereafter) while the EMA continues to analyze their data to determine if the bladder cancer is an early effect or a risk with prolonged use/high cumulative dose.

Although Actos will currently remain on the US market with the new warnings, the FDA will also continue to review the data that comes in from the ongoing, ten-year US epidemiological study. “It’s unsettling that there is data indicating that Actos can lead to bladder cancer, yet patients are expected to ‘wait and see’ while the data is further analyzed,” commented attorney David Ennis. While the FDA continues to review their data, Ennis & Ennis, P.A. continues to investigate bladder cancer claims relating to Actos.

Bladder cancer symptoms may include: blood in urine, painful urination, frequent small amounts of urination, frequent urinary tract infections, lower back pain, and abdominal back pain.

Attorney Ennis recommends that anyone who has taken Actos (pioglitazone) and experienced any of these symptoms should first immediately consult with their physician. Next, the patient should fill out a MedWatch Form with the FDA (https://www.accessdata.fda.gov/scripts/medwatch/medwatch-online.htm). Lastly, patients should seek the opinion of an experienced lawyer to explore their legal rights.

Ennis & Ennis is offering free nationwide confidential consultations for patients who are taking or have taken Actos and suffer these symptoms by calling toll free 1-800-856-6405 or by going to http://www.ennislaw.com and completing an online case evaluation form.

Ennis & Ennis, P.A. is a nationwide law firm with offices in Ft. Lauderdale, Miami and Washington D.C. Ennis & Ennis, P.A. specializes in mass torts and represents individuals against pharmaceutical companies worldwide as well as medical device makers.

Ennis & Ennis, P.A. has been representing clients individually since 1986 and has recovered over $100 million in settlements for its clients.

Ennis & Ennis, P.A. is also investigating cases involving, Accutane, Avandia, Fosamax, Paxil, Zoloft, Prozac, Depuy Hip Recall, Zimmer Hip Recall, Depakote, Reglan, SJS/Dilantin, Yaz, Yasmin and Ocella Birth Control Pills and Transvaginal Mesh Devices.

Remember the law limits the time in which you can file a claim so don't wait to explore your legal rights. Call today toll free 1-800-856-6405 or visit http://www.ennislaw.com .

If you have taken Actos and experienced serious Actos side effects such as Actos Bladder Cancer call our Actos lawyer today to find out about an Actos lawsuit. With offices in Washington D.C. and throughout Florida we are ready to help Actos side effects victims nationwide. Let our Actos Attorneys evaluate your case for free today. Call us toll free at: 1.800.856.6405 for your free, confidential case evaluation.

Under no circumstances should you discontinue taking any medication, including Actos or Pioglitazone, without first consulting with your doctor.

Actos Bladder Cancer Side Effects Lawsuit Information::